Telix Pharmaceuticals has reaffirmed that it will pass US$1 billion in revenue and other income this year. Its third-quarter ...

CSL has named Deborah Waterhouse, a British pharmaceutical executive who helped negotiate Australian medicines policy more ...

GLP-1 medicines were a key part of the update. Sigma said the business was still growing even though the first sales boost from these medicines is now in the base.

Algorae Pharmaceuticals has signed two agreements with Mumbai-based manufacturer Umedica Laboratories. Together, they give ...

Medicines Australia has added two new directors to its board. Anne Harris of Novartis and Ed Hollywood of Boehringer ...

New Zealand's National Party has put medicines back at the centre of its health campaign, promising an additional NZ$604 million for Pharmac if it returns to government at the 7 November election. The ...

The withdrawal follows a series of regulatory actions overseas centred on the drug's pivotal ADVOCATE trial and a growing liver-injury safety signal.

Health technology assessment informs decisions about public funding for new medicines and other health technologies. By the sector's own account, it is also a strong candidate for AI-supported ...

Uh Oh, We've Lost That Page! We're sorry... You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.

In a discussion with BioPharmaDispatch, Professor Hill said the starting point was a set of management questions she put to ...

A year ago, Professor Richard Scolyer, who was living with glioblastoma, stood in Parliament House in Canberra and urged ...